We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expert: GMP Efforts Need Executive-Level Attention, Earlier Focus in Drug Development
Expert: GMP Efforts Need Executive-Level Attention, Earlier Focus in Drug Development
March 6, 2006
Top pharmaceutical executives must play a more active role in overseeing GMP initiatives under the FDA’s new approach to risk management, according to an industry expert who also urged firms to start applying quality manufacturing concepts earlier in the drug development process.